{"gene":"ZPR1","run_date":"2026-06-11T09:02:07","timeline":{"discoveries":[{"year":1996,"finding":"ZPR1 binds to the cytoplasmic tyrosine kinase domain of the epidermal growth factor receptor (EGFR) via its zinc fingers interacting with subdomains X and XI of the EGFR tyrosine kinase; EGF treatment causes decreased ZPR1-EGFR binding in a tyrosine phosphorylation-dependent manner, releasing ZPR1 to accumulate in the nucleus.","method":"Deletion analysis, co-immunoprecipitation, cell fractionation","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal binding mapped by deletion analysis, phosphorylation-dependence demonstrated, replicated in multiple cell assays in the same study","pmids":["8650580"],"is_preprint":false},{"year":1998,"finding":"ZPR1 binds to eukaryotic translation elongation factor-1alpha (eEF-1alpha); EGF treatment induces this interaction and the co-redistribution of both proteins to the nucleus. In yeast, disruption of the ZPR1-eEF-1alpha interaction by mutation causes G2/M accumulation and defective growth, which is rescued by reconstituting the interaction.","method":"Co-immunoprecipitation, mutational analysis, genetic complementation, cell fractionation, yeast growth assays","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — genetic epistasis via reconstitution rescue, mutational disruption, and orthogonal biochemical co-IP across two organisms","pmids":["9852145"],"is_preprint":false},{"year":1998,"finding":"ZPR1 accumulates in the nucleolus of proliferating cells; ZPR1 gene disruption causes loss of nucleolar function including disruption of pre-ribosomal RNA expression, and cells lacking ZPR1 are not viable.","method":"Gene disruption (knockout), subcellular fractionation, fluorescence microscopy, pre-rRNA expression analysis","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct localization with functional consequence (nucleolar disruption, pre-rRNA defect) established by gene disruption with specific molecular readout","pmids":["9763455"],"is_preprint":false},{"year":2001,"finding":"ZPR1 interacts with the SMN protein and both proteins co-localize in subnuclear structures including gems and Cajal bodies; serum stimulation causes redistribution of SMN and ZPR1 from cytoplasm to nucleus, a process disrupted in SMA type I patient cells with SMN1 mutations. Decreased ZPR1 expression prevents SMN localization to nuclear bodies.","method":"Co-immunoprecipitation, fluorescence microscopy, siRNA/antisense knockdown, patient cell analysis","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, direct localization experiment with functional consequence, validated in patient cells and knockdown models","pmids":["11283611"],"is_preprint":false},{"year":2002,"finding":"Cyclophilin A (Cpr1p) PPIase activity is required for nuclear export of Zpr1p in yeast; in cpr1Δ cells or with CPR1-dependent ZPR1 mutant alleles, Zpr1p accumulates in the nucleus due to defective export. PPIase activity of cyclophilins and structurally unrelated PPIase Fpr1p can suppress this defect, and overexpression of EF1alpha (a Zpr1p binding partner) also suppresses it.","method":"Yeast genetics (suppressor screen), nuclear export kinetic studies, fluorescence microscopy, mutant cyclophilin complementation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with transport kinetics, multiple orthogonal suppressors tested, PPIase activity correlation established","pmids":["12242280"],"is_preprint":false},{"year":2005,"finding":"Targeted ablation of Zpr1 in mice disrupts subcellular localization of SMN to Cajal bodies and gems, and reduces cytoplasmic snRNP levels. Zpr1-/- mice die during early embryonic development with reduced proliferation and increased apoptosis. In motor neuron-like cells, siRNA-mediated ZPR1 depletion causes growth cone retraction, axonal defects, and apoptosis.","method":"Conditional gene knockout (mouse), siRNA knockdown, immunofluorescence microscopy, snRNP immunoprecipitation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knockout with specific molecular (snRNP, SMN localization) and cellular phenotypes, confirmed by siRNA in a second system","pmids":["15767679"],"is_preprint":false},{"year":2006,"finding":"ZPR1 redistributes to the nucleus during S phase and co-localizes with SMN and the histone transcription factor NPAT at Cajal bodies associated with histone gene clusters. ZPR1 deficiency disrupts SMN and NPAT nuclear localization, blocks S-phase progression, arrests cells in G1 and G2 phases, and decreases histone gene expression.","method":"Cell cycle synchronization, fluorescence microscopy, siRNA knockdown, flow cytometry, RT-PCR for histone gene expression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct localization tied to functional consequence (histone gene expression, cell cycle arrest) with multiple orthogonal readouts","pmids":["17068332"],"is_preprint":false},{"year":2006,"finding":"ZPR1-deficient mice (heterozygous Zpr1 reduction) exhibit axonal pathology and neurodegeneration, identifying ZPR1 deficiency as a contributing factor in neurodegenerative disorders.","method":"Mouse model with targeted Zpr1 gene ablation, histopathological analysis of spinal cord","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single study, in vivo knockout with neurodegeneration phenotype but limited molecular mechanism detail in abstract","pmids":["16648254"],"is_preprint":false},{"year":2007,"finding":"Crystal structure of the ZPR1 domain tandem revealed that each ZPR1 domain consists of an EIF2-like zinc finger and a double-stranded beta helix with a helical hairpin insertion. ZPR1 binds preferentially to GDP-bound eEF1A, does not directly influence nucleotide exchange kinetics or GTP hydrolysis, but efficiently displaces the exchange factor eEF1Bα from preformed nucleotide-free complexes, suggesting a role as a negative regulator of eEF1A activation. Structure-based mutagenesis identified a conserved eEF1A binding epitope required for normal cell growth, proliferation, and cell cycle progression.","method":"X-ray crystallography, biochemical binding assays, structure-based mutagenesis, complementation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure combined with mutagenesis, in vitro biochemical assays, and functional complementation in a single rigorous study","pmids":["17704259"],"is_preprint":false},{"year":2009,"finding":"A ZPR1 deletion mutant (ΔA, Δ193-246) binds eEF1alpha constitutively and independently of Zn2+ in vivo, defining a region that normally controls the Zn2+-dependence of the ZPR1-eEF1alpha interaction.","method":"Mutational analysis, co-immunoprecipitation in vivo","journal":"Bioscience, biotechnology, and biochemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — single co-IP/pulldown approach, single lab, limited mechanistic follow-up","pmids":["19966453"],"is_preprint":false},{"year":2012,"finding":"In Drosophila, Zpr1 is required downstream of both EGFR and FGFR signaling for tracheal subcellular lumen formation; Zpr1 mutations block lumen maturation, EGFR down-regulation phenocopies Zpr1 mutation, and Zpr1 is epistatic to EGFR overexpression-driven lumen formation. Reduction of Smn (a ZPR1-interacting protein) produces similar defects.","method":"Forward genetic mosaic screen, genetic epistasis analysis, RNAi knockdown in Drosophila","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with multiple pathways, confirmed by orthogonal RNAi and morphological readouts in single study","pmids":["23029159"],"is_preprint":false},{"year":2017,"finding":"ZPR1 functions downstream of SMN to regulate HoxA5 levels in phrenic motor neurons; spatiotemporal inactivation of Zpr1 in motor neurons down-regulates HoxA5 and causes defects in phrenic motor neuron function resulting in respiratory failure and perinatal lethality in mice. Modulation of ZPR1 levels directly correlates with HoxA5 transcription levels in SMA mice.","method":"Conditional motor neuron-specific Zpr1 knockout (mouse), quantitative gene expression analysis, respiratory function assays","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional in vivo knockout with specific molecular target (HoxA5) and functional respiratory phenotype, direct correlation between ZPR1 and HoxA5 levels","pmids":["28811488"],"is_preprint":false},{"year":2018,"finding":"ZNF259/ZPR1 promotes breast cancer cell invasion and migration by activating the ERK/GSK3β/Snail signaling pathway; ZNF259 knockdown reduces p-ERK, p-GSK3β, and Snail and upregulates E-cadherin/ZO-1, while ZNF259 overexpression has the opposite effects. ERK inhibitor U0126 reverses effects of ZNF259 overexpression.","method":"siRNA knockdown, plasmid overexpression, Western blotting, Matrigel invasion assay, wound healing assay, pharmacological inhibition","journal":"Cancer management and research","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — loss-of-function and gain-of-function with pathway inhibitor rescue, multiple cellular readouts, single lab","pmids":["30214308"],"is_preprint":false},{"year":2018,"finding":"A homozygous missense mutation in ZPR1 (p.Ile196Thr) causes complete loss of ZPR1 protein in patient fibroblasts and a cell cycle defect with a significant number of cells arrested in G1 phase; structural modeling indicates this mutation disrupts the hydrophobic core of ZPR1.","method":"Exome sequencing, Western blot (no detectable ZPR1 protein), flow cytometry cell cycle analysis, structural modeling","journal":"Clinical genetics","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — human mutation with molecular (protein loss) and cellular (G1 arrest) phenotype, structural model supporting mechanism, single study","pmids":["29851065"],"is_preprint":false},{"year":2019,"finding":"ZPR1-dependent neurodegeneration is mediated by the JNK signaling pathway, specifically through CNS-specific JNK3; ZPR1 deficiency activates the MLK3→MKK7→JNK3 cascade, phosphorylates c-Jun, and activates caspase-mediated neuron degeneration. Neurons from Jnk3-null mice are resistant to ZPR1-dependent neurodegeneration, and pharmacologic JNK inhibition reduces degeneration.","method":"Mouse genetic models (Jnk3 knockout, Zpr1-deficient), pharmacological JNK inhibition, Western blotting for signaling intermediates, apoptosis assays","journal":"Journal of experimental neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis (Jnk3 null rescue) plus pharmacological inhibition plus molecular pathway validation in multiple orthogonal approaches","pmids":["31488953"],"is_preprint":false},{"year":2019,"finding":"ZNF259/ZPR1 depletion in lung cancer cells leads to enhanced p-FAK and p-AKT, CyclinD1, and MMP2 levels, increasing proliferation and invasion; effects are reversed by specific FAK or AKT inhibitors, placing ZNF259 upstream of the FAK-AKT pathway as an inhibitor.","method":"siRNA knockdown, Western blotting, invasion and proliferation assays, pharmacological inhibition","journal":"Cancer management and research","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — loss-of-function with pathway inhibitor rescue and multiple readouts, single lab","pmids":["29276408"],"is_preprint":false},{"year":2020,"finding":"ZPR1 binds to RNA polymerase II and interacts in vivo with the SMN locus to upregulate SMN2 expression; ZPR1 overexpression in vivo increases SMN levels systemically and rescues severe SMA in mice. Low ZPR1 levels cause accumulation of co-transcriptional R-loops and DNA damage; ZPR1 complementation elevates senataxin levels, reduces R-loop accumulation and rescues DNA damage in SMA mice, motor neurons, and patient cells.","method":"Co-immunoprecipitation with RNA Pol II, chromatin immunoprecipitation (ChIP) at SMN locus, in vivo transgenic overexpression, R-loop detection assays (S9.6 antibody), DNA damage assays, senataxin protein quantification","journal":"Brain","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches (ChIP, Co-IP, in vivo rescue, R-loop quantification, DNA damage) across patient cells and mouse models in a single comprehensive study","pmids":["31828288"],"is_preprint":false},{"year":2023,"finding":"Zpr1 is a bespoke chaperone dedicated to eEF1A biogenesis; Zpr1 depletion causes acute proteotoxicity from misfolded eEF1A biosynthesis, and prolonged depletion causes eEF1A insufficiency inducing the integrated stress response and inhibiting protein synthesis. Biochemical reconstitution demonstrated that Zpr1 enables eEF1A to achieve a protease-resistant conformational state. ColabFold structural modeling revealed that Zpr1's zinc-finger and alpha-helical hairpin structures mediate the folding mechanism.","method":"Biochemical reconstitution (two approaches), protease protection assay, structural modeling (ColabFold), yeast genetic depletion, polysome profiling","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — two independent biochemical reconstitutions, structural modeling with functional validation, multiple genetic and cell biological readouts in a single rigorous study","pmids":["36630955"],"is_preprint":false},{"year":2023,"finding":"Folding of eEF1A by Zpr1 requires GTP hydrolysis by eEF1A. The conserved protein Aim29 acts as a Zpr1 co-chaperone that recognizes eEF1A in the GTP-bound pre-hydrolysis conformation, dampens Zpr1·eEF1A GTPase activity, and facilitates client exit from the folding cycle.","method":"Biochemical reconstitution, GTPase activity assays, yeast genetics, fluorescence microscopy, structural modeling","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — biochemical reconstitution with GTPase assays and genetic validation, single lab but multiple orthogonal methods","pmids":["37597513"],"is_preprint":false},{"year":2023,"finding":"ZPR1 assembles via liquid-liquid phase separation (LLPS) in vitro and regulates CHOP-mediated UPRER at the transcriptional level. ZPR1 binding to K63-ubiquitin chains promotes its LLPS. The bacterial effector NleE (from EPEC) disrupts ZPR1 binding to K63-ubiquitin chains, thereby inhibiting ZPR1 LLPS and suppressing host UPRER.","method":"Proximity-enabled protein crosslinking (to identify interaction), in vitro LLPS assay, ubiquitin chain binding assay, CHOP transcription reporter assay","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — novel interaction identified by crosslinking, LLPS and ubiquitin binding validated in vitro, transcriptional function shown, single lab","pmids":["37379216"],"is_preprint":false},{"year":2025,"finding":"ZPR1 depletion decreased viral (HPV) R-loops while enhancing cellular R-loops, and increased SETX binding to the viral promoter. E2-ZPR1-SETX complex was detected. ZPR1 is thus not required for HPV R-loop resolution but regulates host R-loop dynamics, in contrast to its previously described role in resolving R-loops in mammalian cells.","method":"Co-immunoprecipitation (E2-SETX-ZPR1 complex), siRNA depletion, R-loop detection (S9.6), ChIP for SETX at viral promoter","journal":"Viruses","confidence":"Medium","confidence_rationale":"Tier 2-3 / Weak — single study, siRNA depletion with R-loop and ChIP readouts; the negative finding (ZPR1 not required for HPV R-loop resolution) is mechanistically informative","pmids":["41305523"],"is_preprint":false}],"current_model":"ZPR1 (ZNF259) is an essential, highly conserved zinc-finger protein that acts as a bespoke chaperone for eEF1A biogenesis (enabling its proper folding through a GTPase-regulated cycle assisted by the co-chaperone Aim29), translocates from cytoplasm to nucleus in response to mitogenic signals (including EGF via EGFR tyrosine kinase interaction), accumulates in the nucleolus and Cajal bodies where it is required for pre-rRNA expression and histone gene transcription, regulates SMN complex localization to nuclear bodies (with deficiency causing SMA-like neurodegeneration via JNK3-mediated apoptosis), upregulates SMN2 expression through RNA Pol II interaction and prevents genomic instability by maintaining senataxin levels to resolve co-transcriptional R-loops, and undergoes liquid-liquid phase separation regulated by K63-ubiquitin binding to modulate the UPRER."},"narrative":{"mechanistic_narrative":"ZPR1 (ZNF259) is an essential, zinc-finger protein that couples eEF1A biogenesis to mitogenic signaling and nuclear organization [PMID:9852145, PMID:9763455, PMID:36630955]. Its core biochemical activity is to act as a dedicated chaperone for the translation elongation factor eEF1A: ZPR1 binds preferentially the GDP-bound form of eEF1A through a conserved binding epitope, displaces the exchange factor eEF1Bα, and drives eEF1A into a protease-resistant folded state via a GTP-hydrolysis-dependent cycle assisted by the co-chaperone Aim29 [PMID:17704259, PMID:36630955, PMID:37597513]. Loss of ZPR1 causes proteotoxic accumulation of misfolded eEF1A, eEF1A insufficiency, induction of the integrated stress response, and inhibition of protein synthesis [PMID:36630955]. In quiescent cells ZPR1 is held at the cytoplasmic tyrosine kinase domain of EGFR; EGF-induced receptor tyrosine phosphorylation releases ZPR1, which redistributes with eEF1A to the nucleus, accumulates in the nucleolus, and is required for pre-rRNA expression and cell viability [PMID:8650580, PMID:9852145, PMID:9763455]. During S phase ZPR1 co-localizes with SMN and the histone transcription factor NPAT in Cajal bodies, where it is required for SMN and NPAT nuclear localization, histone gene expression, and cell-cycle progression [PMID:11283611, PMID:17068332]. ZPR1 regulates SMN biology directly: it binds RNA polymerase II at the SMN locus to upregulate SMN2, and maintains senataxin levels to resolve co-transcriptional R-loops and prevent DNA damage, so that ZPR1 deficiency drives SMA-like motor neuron degeneration through an MLK3→MKK7→JNK3 apoptotic cascade [PMID:31488953, PMID:31828288]. A homozygous p.Ile196Thr missense mutation that abolishes ZPR1 protein causes a G1 cell-cycle defect in patient fibroblasts, establishing ZPR1 loss as a human disease determinant [PMID:29851065]. ZPR1 additionally assembles by K63-ubiquitin-promoted liquid-liquid phase separation to regulate CHOP-mediated UPRER transcription [PMID:37379216].","teleology":[{"year":1996,"claim":"Established the first molecular handle on ZPR1 by showing it is a signaling-responsive partner of a receptor tyrosine kinase, linking growth-factor input to ZPR1 relocalization.","evidence":"Deletion mapping and co-IP showing zinc-finger binding to EGFR subdomains X/XI with phosphorylation-dependent release and nuclear accumulation","pmids":["8650580"],"confidence":"High","gaps":["Did not identify downstream nuclear targets of released ZPR1","Functional consequence of EGFR binding for translation or proliferation untested"]},{"year":1998,"claim":"Identified eEF1A as a core ZPR1 partner and demonstrated the interaction is functionally essential, tying ZPR1 to translation machinery and cell-cycle progression.","evidence":"Co-IP, mutational disruption with reconstitution rescue, and cell fractionation in mammalian cells and yeast","pmids":["9852145","9763455"],"confidence":"High","gaps":["Mechanism of how ZPR1 acts on eEF1A undefined","Whether the eEF1A interaction explains nucleolar/pre-rRNA requirement unresolved"]},{"year":2001,"claim":"Connected ZPR1 to the SMN pathway, showing ZPR1 is required for SMN delivery to nuclear bodies, providing a mechanistic basis for ZPR1 involvement in spinal muscular atrophy.","evidence":"Reciprocal co-IP, immunofluorescence in gems/Cajal bodies, knockdown, and SMA type I patient cell analysis","pmids":["11283611"],"confidence":"High","gaps":["Did not establish whether ZPR1 acts on SMN transcription or trafficking","Mechanism of serum-stimulated co-redistribution not defined"]},{"year":2002,"claim":"Defined how ZPR1 nuclear export is controlled, showing PPIase (cyclophilin) activity and eEF1A availability govern its shuttling.","evidence":"Yeast suppressor genetics, nuclear export kinetics, and cyclophilin complementation","pmids":["12242280"],"confidence":"High","gaps":["Direct prolyl isomerization of ZPR1 not demonstrated","Mammalian relevance of cyclophilin-dependent export untested"]},{"year":2005,"claim":"Demonstrated ZPR1 is essential in vivo and required for SMN/snRNP nuclear body assembly and motor neuron integrity.","evidence":"Mouse Zpr1 knockout (embryonic lethal), siRNA in motor neuron-like cells, snRNP IP, and immunofluorescence","pmids":["15767679"],"confidence":"High","gaps":["Molecular cause of apoptosis not yet defined","Tissue-specific requirements not dissected"]},{"year":2006,"claim":"Linked ZPR1 to S-phase histone gene transcription and confirmed its in vivo role in neurodegeneration.","evidence":"Cell-cycle synchronization with NPAT/Cajal body colocalization, histone RT-PCR, and Zpr1-reduced mouse spinal cord histopathology","pmids":["17068332","16648254"],"confidence":"High","gaps":["Direct ZPR1 occupancy at histone loci not shown","Connection between histone transcription role and neurodegeneration unclear"]},{"year":2007,"claim":"Provided structural and biochemical mechanism for the ZPR1–eEF1A interaction, defining ZPR1 as a regulator of eEF1A nucleotide state.","evidence":"Crystal structure of ZPR1 domain tandem, binding assays showing GDP-eEF1A preference and eEF1Bα displacement, and structure-guided mutagenesis with complementation","pmids":["17704259"],"confidence":"High","gaps":["Cellular consequence of eEF1Bα displacement not directly measured","Did not yet identify the chaperone activity later described"]},{"year":2009,"claim":"Mapped a regulatory region (residues 193–246) that confers Zn2+-dependence on the ZPR1–eEF1A interaction.","evidence":"Deletion mutant (ΔA) co-IP showing constitutive, Zn2+-independent eEF1A binding","pmids":["19966453"],"confidence":"Medium","gaps":["Single co-IP approach without orthogonal validation","Structural basis of Zn2+ regulation not resolved"]},{"year":2012,"claim":"Placed ZPR1 within receptor tyrosine kinase developmental signaling in an organismal context, downstream of EGFR/FGFR.","evidence":"Drosophila genetic mosaic screen and epistasis for tracheal lumen formation, with Smn phenocopy","pmids":["23029159"],"confidence":"Medium","gaps":["Molecular target of ZPR1 in lumen formation unknown","Relationship to translation/eEF1A role not addressed"]},{"year":2017,"claim":"Identified HoxA5 as a ZPR1-dependent transcriptional output critical for motor neuron function, linking ZPR1/SMN to respiratory phenotypes.","evidence":"Motor neuron-specific conditional Zpr1 knockout in mice with HoxA5 expression analysis and respiratory assays","pmids":["28811488"],"confidence":"High","gaps":["Whether ZPR1 regulates HoxA5 directly or via SMN unclear","Mechanism connecting HoxA5 to phrenic neuron survival not defined"]},{"year":2018,"claim":"Revealed ZPR1 loss causes a human cell-cycle disease phenotype and that ZPR1 modulates oncogenic signaling, broadening its physiological scope.","evidence":"Patient exome (p.Ile196Thr, protein loss, G1 arrest) and ERK/GSK3β/Snail pathway manipulation in breast cancer cells with inhibitor rescue","pmids":["29851065","30214308"],"confidence":"Medium","gaps":["Disease entity caused by the mutation not fully characterized","Direct vs indirect effect on ERK/Snail signaling not resolved"]},{"year":2019,"claim":"Defined the apoptotic effector pathway of ZPR1 deficiency (JNK3) and an additional tumor-suppressive signaling context (FAK-AKT).","evidence":"Jnk3-null genetic rescue plus pharmacological JNK inhibition for neurodegeneration; siRNA with FAK/AKT inhibitor rescue in lung cancer cells","pmids":["31488953","29276408"],"confidence":"High","gaps":["Upstream trigger linking ZPR1 loss to MLK3 activation unknown","Whether translation defects drive JNK3 activation untested"]},{"year":2020,"claim":"Established a direct gene-regulatory mechanism by which ZPR1 upregulates SMN2 and protects the genome from R-loop-driven damage via senataxin.","evidence":"RNA Pol II co-IP, ChIP at the SMN locus, in vivo transgenic overexpression rescue of SMA, S9.6 R-loop and DNA damage assays, and senataxin quantification","pmids":["31828288"],"confidence":"High","gaps":["Mechanism by which ZPR1 maintains senataxin levels unresolved","Whether transcriptional and chaperone functions are mechanistically linked unclear"]},{"year":2023,"claim":"Resolved the molecular function of ZPR1 as a bespoke eEF1A folding chaperone operating through a GTP-hydrolysis cycle with co-chaperone Aim29.","evidence":"Two independent biochemical reconstitutions, protease-protection assays, GTPase assays, ColabFold modeling, and yeast genetics","pmids":["36630955","37597513"],"confidence":"High","gaps":["High-resolution structure of the ZPR1·eEF1A·Aim29 folding intermediate lacking","Human Aim29 ortholog and in-cell coupling to disease phenotypes not established"]},{"year":2023,"claim":"Added a phase-separation-based regulatory mode, linking ZPR1 ubiquitin recognition to ER stress transcription and host-pathogen control.","evidence":"Proximity crosslinking, in vitro LLPS and K63-ubiquitin binding assays, CHOP reporter, and bacterial NleE effector disruption","pmids":["37379216"],"confidence":"Medium","gaps":["Physiological trigger of ZPR1 LLPS in cells unconfirmed","Relationship between LLPS and the eEF1A chaperone function unknown"]},{"year":2025,"claim":"Refined the R-loop role, showing ZPR1 regulates host versus viral R-loop dynamics differentially via a SETX-containing complex.","evidence":"E2-ZPR1-SETX co-IP, siRNA depletion, S9.6 R-loop detection, and SETX ChIP at the HPV promoter","pmids":["41305523"],"confidence":"Medium","gaps":["Single study with siRNA depletion","Mechanism distinguishing host vs viral R-loop regulation unclear"]},{"year":null,"claim":"How ZPR1's distinct activities — cytoplasmic eEF1A chaperoning, nuclear SMN/SMN2 regulation, R-loop resolution, and phase separation — are coordinated within a single protein remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model integrating chaperone and transcriptional/genome-protective roles","Mechanism of signal-dependent partitioning between functions unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[17,18]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[8]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[16,6]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[1,8]}],"localization":[{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[2]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1,3]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,1]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[3,6]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[17,18]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[16,6]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[16]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,12,15]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[6,13]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[17,19]}],"complexes":["Cajal body","ZPR1·eEF1A·Aim29 folding complex"],"partners":["EEF1A1","SMN1","EGFR","NPAT","SETX","AIM29","EEF1B"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O75312","full_name":"Zinc finger protein ZPR1","aliases":["Zinc finger protein 259"],"length_aa":459,"mass_kda":50.9,"function":"Acts as a signaling molecule that communicates proliferative growth signals from the cytoplasm to the nucleus. It is involved in the positive regulation of cell cycle progression (PubMed:29851065). Plays a role for the localization and accumulation of the survival motor neuron protein SMN1 in sub-nuclear bodies, including gems and Cajal bodies. Induces neuron differentiation and stimulates axonal growth and formation of growth cone in spinal cord motor neurons. Plays a role in the splicing of cellular pre-mRNAs. May be involved in H(2)O(2)-induced neuronal cell death","subcellular_location":"Nucleus; Nucleus, nucleolus; Nucleus, gem; Nucleus, Cajal body; Cytoplasm, perinuclear region; Cytoplasm; Cell projection, axon; Cell projection, growth cone","url":"https://www.uniprot.org/uniprotkb/O75312/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/ZPR1","classification":"Common Essential","n_dependent_lines":1201,"n_total_lines":1208,"dependency_fraction":0.9942052980132451},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ZPR1","total_profiled":1310},"omim":[{"mim_id":"619321","title":"GROWTH RESTRICTION, HYPOPLASTIC KIDNEYS, ALOPECIA, AND DISTINCTIVE FACIES; GKAF","url":"https://www.omim.org/entry/619321"},{"mim_id":"610942","title":"MICRO RNA 204; MIR204","url":"https://www.omim.org/entry/610942"},{"mim_id":"608465","title":"SENATAXIN; SETX","url":"https://www.omim.org/entry/608465"},{"mim_id":"603901","title":"ZPR1 ZINC FINGER PROTEIN; ZPR1","url":"https://www.omim.org/entry/603901"},{"mim_id":"601627","title":"SURVIVAL OF MOTOR NEURON 2; SMN2","url":"https://www.omim.org/entry/601627"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ZPR1"},"hgnc":{"alias_symbol":[],"prev_symbol":["ZNF259"]},"alphafold":{"accession":"O75312","domains":[{"cath_id":"2.20.25.420","chopping":"42-93","consensus_level":"high","plddt":74.3694,"start":42,"end":93},{"cath_id":"2.60.120.1040","chopping":"101-233","consensus_level":"high","plddt":88.3005,"start":101,"end":233},{"cath_id":"2.20.25.420","chopping":"254-301","consensus_level":"high","plddt":80.8865,"start":254,"end":301},{"cath_id":"2.60.120.1040","chopping":"309-370_380-442","consensus_level":"high","plddt":89.9589,"start":309,"end":442}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O75312","model_url":"https://alphafold.ebi.ac.uk/files/AF-O75312-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O75312-F1-predicted_aligned_error_v6.png","plddt_mean":79.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ZPR1","jax_strain_url":"https://www.jax.org/strain/search?query=ZPR1"},"sequence":{"accession":"O75312","fasta_url":"https://rest.uniprot.org/uniprotkb/O75312.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O75312/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O75312"}},"corpus_meta":[{"pmid":"11283611","id":"PMC_11283611","title":"Spinal muscular atrophy disrupts the interaction of ZPR1 with the SMN protein.","date":"2001","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11283611","citation_count":117,"is_preprint":false},{"pmid":"8650580","id":"PMC_8650580","title":"Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor.","date":"1996","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8650580","citation_count":102,"is_preprint":false},{"pmid":"9852145","id":"PMC_9852145","title":"Interaction of ZPR1 with translation elongation factor-1alpha in proliferating cells.","date":"1998","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9852145","citation_count":93,"is_preprint":false},{"pmid":"9763455","id":"PMC_9763455","title":"The cytoplasmic zinc finger protein ZPR1 accumulates in the nucleolus of proliferating cells.","date":"1998","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/9763455","citation_count":73,"is_preprint":false},{"pmid":"15767679","id":"PMC_15767679","title":"ZPR1 is essential for survival and is required for localization of the survival motor neurons (SMN) protein to Cajal bodies.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15767679","citation_count":62,"is_preprint":false},{"pmid":"12242280","id":"PMC_12242280","title":"Cyclophilin A peptidyl-prolyl isomerase activity promotes ZPR1 nuclear export.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12242280","citation_count":57,"is_preprint":false},{"pmid":"22422766","id":"PMC_22422766","title":"The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22422766","citation_count":56,"is_preprint":false},{"pmid":"31828288","id":"PMC_31828288","title":"ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy.","date":"2020","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31828288","citation_count":53,"is_preprint":false},{"pmid":"17068332","id":"PMC_17068332","title":"Deficiency of the zinc finger protein ZPR1 causes defects in transcription and cell cycle progression.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17068332","citation_count":46,"is_preprint":false},{"pmid":"27411854","id":"PMC_27411854","title":"Two-stage association study to identify the genetic susceptibility of a novel common variant of rs2075290 in ZPR1 to type 2 diabetes.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27411854","citation_count":46,"is_preprint":false},{"pmid":"16648254","id":"PMC_16648254","title":"Deficiency of the zinc finger protein ZPR1 causes neurodegeneration.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16648254","citation_count":43,"is_preprint":false},{"pmid":"17704259","id":"PMC_17704259","title":"Structural insights into the interaction of the evolutionarily conserved ZPR1 domain tandem with eukaryotic EF1A, receptors, and SMN complexes.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17704259","citation_count":41,"is_preprint":false},{"pmid":"24780069","id":"PMC_24780069","title":"Association of the variants in the BUD13-ZNF259 genes and the risk of hyperlipidaemia.","date":"2014","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24780069","citation_count":38,"is_preprint":false},{"pmid":"26405538","id":"PMC_26405538","title":"Association of FURIN and ZPR1 polymorphisms with metabolic syndrome.","date":"2015","source":"Biomedical reports","url":"https://pubmed.ncbi.nlm.nih.gov/26405538","citation_count":31,"is_preprint":false},{"pmid":"26397108","id":"PMC_26397108","title":"Effects of Polymorphisms in APOA4-APOA5-ZNF259-BUD13 Gene Cluster on Plasma Levels of Triglycerides and Risk of Coronary Heart Disease in a Chinese Han Population.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26397108","citation_count":20,"is_preprint":false},{"pmid":"28245265","id":"PMC_28245265","title":"Admixture mapping in two Mexican samples identifies significant associations of locus ancestry with triglyceride levels in the BUD13/ZNF259/APOA5 region and fine mapping points to rs964184 as the main driver of the association signal.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28245265","citation_count":18,"is_preprint":false},{"pmid":"30214308","id":"PMC_30214308","title":"ZNF259 promotes breast cancer cells invasion and migration via ERK/GSK3β/snail signaling.","date":"2018","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/30214308","citation_count":17,"is_preprint":false},{"pmid":"28811488","id":"PMC_28811488","title":"Deregulation of ZPR1 causes respiratory failure in spinal muscular atrophy.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28811488","citation_count":16,"is_preprint":false},{"pmid":"36630955","id":"PMC_36630955","title":"Zinc-finger protein Zpr1 is a bespoke chaperone essential for eEF1A biogenesis.","date":"2023","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/36630955","citation_count":15,"is_preprint":false},{"pmid":"27928822","id":"PMC_27928822","title":"Solanum tuberosum ZPR1 encodes a light-regulated nuclear DNA-binding protein adjusting the circadian expression of StBBX24 to light cycle.","date":"2017","source":"Plant, cell & environment","url":"https://pubmed.ncbi.nlm.nih.gov/27928822","citation_count":15,"is_preprint":false},{"pmid":"31165758","id":"PMC_31165758","title":"Association of BUD13-ZNF259-APOA5-APOA1-SIK3 cluster polymorphism in 11q23.3 and structure of APOA5 with increased plasma triglyceride levels in a Korean population.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31165758","citation_count":15,"is_preprint":false},{"pmid":"31488953","id":"PMC_31488953","title":"ZPR1-Dependent Neurodegeneration Is Mediated by the JNK Signaling Pathway.","date":"2019","source":"Journal of experimental neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31488953","citation_count":14,"is_preprint":false},{"pmid":"25469254","id":"PMC_25469254","title":"Association of a genetic variant of the ZPR1 zinc finger gene with type 2 diabetes mellitus.","date":"2014","source":"Biomedical reports","url":"https://pubmed.ncbi.nlm.nih.gov/25469254","citation_count":13,"is_preprint":false},{"pmid":"33986338","id":"PMC_33986338","title":"Kernel machine SNP set analysis finds the association of BUD13, ZPR1, and APOA5 variants with metabolic syndrome in Tehran Cardio-metabolic Genetics Study.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33986338","citation_count":13,"is_preprint":false},{"pmid":"29276408","id":"PMC_29276408","title":"ZNF259 inhibits non-small cell lung cancer cells proliferation and invasion by FAK-AKT signaling.","date":"2017","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/29276408","citation_count":12,"is_preprint":false},{"pmid":"30631647","id":"PMC_30631647","title":"Functional polymorphisms of the APOA1/C3/A4/A5-ZPR1-BUD13 gene cluster are associated with dyslipidemia in a sex-specific pattern.","date":"2019","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/30631647","citation_count":12,"is_preprint":false},{"pmid":"26118197","id":"PMC_26118197","title":"Zinc Finger Protein 259 (ZNF259) Polymorphisms are Associated with the Risk of Metabolic Syndrome in a Han Chinese Population.","date":"2015","source":"Clinical laboratory","url":"https://pubmed.ncbi.nlm.nih.gov/26118197","citation_count":10,"is_preprint":false},{"pmid":"26885234","id":"PMC_26885234","title":"Association study of BUD13-ZNF259 gene rs964184 polymorphism and hemorrhagic stroke risk.","date":"2015","source":"International journal of clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26885234","citation_count":8,"is_preprint":false},{"pmid":"37379216","id":"PMC_37379216","title":"Bacterial effector restricts liquid-liquid phase separation of ZPR1 to antagonize host UPRER.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37379216","citation_count":8,"is_preprint":false},{"pmid":"29851065","id":"PMC_29851065","title":"A ZPR1 mutation is associated with a novel syndrome of growth restriction, distinct craniofacial features, alopecia, and hypoplastic kidneys.","date":"2018","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29851065","citation_count":8,"is_preprint":false},{"pmid":"31181149","id":"PMC_31181149","title":"Interaction of polymorphisms in APOA4-APOA5-ZPR1-BUD13 gene cluster and sleep duration on 5-year lipid changes in middle aged and older Chinese.","date":"2019","source":"Sleep","url":"https://pubmed.ncbi.nlm.nih.gov/31181149","citation_count":8,"is_preprint":false},{"pmid":"16465397","id":"PMC_16465397","title":"Expression of zinc finger protein ZPR1 mRNA in brain is up-regulated in mice fed a high-fat diet.","date":"2006","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16465397","citation_count":7,"is_preprint":false},{"pmid":"23029159","id":"PMC_23029159","title":"Drosophila Zpr1 (Zinc finger protein 1) is required downstream of both EGFR and FGFR signaling in tracheal subcellular lumen formation.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23029159","citation_count":7,"is_preprint":false},{"pmid":"32807694","id":"PMC_32807694","title":"The ZPR1 genotype predicts myocardial infarction in patients with familial hypercholesterolemia.","date":"2020","source":"Journal of clinical lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/32807694","citation_count":7,"is_preprint":false},{"pmid":"30902787","id":"PMC_30902787","title":"There is an association between a genetic polymorphism in the ZNF259 gene involved in lipid metabolism and coronary artery disease.","date":"2019","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/30902787","citation_count":6,"is_preprint":false},{"pmid":"35782928","id":"PMC_35782928","title":"A Gene Variation at the ZPR1 Locus (rs964184) Interacts With the Type of Diet to Modulate Postprandial Triglycerides in Patients With Coronary Artery Disease: From the Coronary Diet Intervention With Olive Oil and Cardiovascular Prevention Study.","date":"2022","source":"Frontiers in nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/35782928","citation_count":5,"is_preprint":false},{"pmid":"37964506","id":"PMC_37964506","title":"ZPR1 is an immunodiagnostic biomarker and promotes tumor progression in esophageal squamous cell carcinoma.","date":"2023","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/37964506","citation_count":4,"is_preprint":false},{"pmid":"37597513","id":"PMC_37597513","title":"A Zpr1 co-chaperone mediates folding of eukaryotic translation elongation factor 1A via a GTPase cycle.","date":"2023","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/37597513","citation_count":4,"is_preprint":false},{"pmid":"34746842","id":"PMC_34746842","title":"High-fat diet-associated cognitive decline: Is zinc finger protein 1 (ZPR1) the molecular connection?","date":"2021","source":"Current research in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/34746842","citation_count":4,"is_preprint":false},{"pmid":"31670185","id":"PMC_31670185","title":"Polymorphisms in genes that affect the variation of lipid levels in a Brazilian pediatric population with sickle cell disease: rs662799 APOA5 and rs964184 ZPR1.","date":"2019","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/31670185","citation_count":4,"is_preprint":false},{"pmid":"19966453","id":"PMC_19966453","title":"Generation of a zinc finger protein ZPR1 mutant that constitutively interacted with translation elongation factor 1alpha.","date":"2009","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19966453","citation_count":2,"is_preprint":false},{"pmid":"40665476","id":"PMC_40665476","title":"Genome-wide study links cardiometabolic factors to cognition via APOA4-APOA5-ZPR1-BUD13 and other loci in rural Indians.","date":"2025","source":"Alzheimer's & dementia : the journal of the Alzheimer's Association","url":"https://pubmed.ncbi.nlm.nih.gov/40665476","citation_count":1,"is_preprint":false},{"pmid":"41305523","id":"PMC_41305523","title":"ZPR1 Is Dispensable for HPV R-Loop Resolution but Regulates Host R-Loop Dynamics.","date":"2025","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/41305523","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.05.15.25327712","title":"Shared proteomic landscape between arteriosclerosis and cardiovascular endpoints: a Mendelian randomization and observational study integrating AlphaFold3 for structural prediction","date":"2025-05-16","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.15.25327712","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.11.21.25340771","title":"A sex-specific genome-wide association study of blood lipid levels in All of Us","date":"2025-11-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.21.25340771","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.09.04.24313052","title":"Pharmacogenetic Study of Antipsychotic-Induced Lipid and BMI Changes in Chinese Schizophrenia Patients: A Genome-Wide Association Study","date":"2024-09-04","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.04.24313052","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":24745,"output_tokens":5389,"usd":0.077535,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13975,"output_tokens":5243,"usd":0.100475,"stage2_stop_reason":"end_turn"},"total_usd":0.17801,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"ZPR1 binds to the cytoplasmic tyrosine kinase domain of the epidermal growth factor receptor (EGFR) via its zinc fingers interacting with subdomains X and XI of the EGFR tyrosine kinase; EGF treatment causes decreased ZPR1-EGFR binding in a tyrosine phosphorylation-dependent manner, releasing ZPR1 to accumulate in the nucleus.\",\n      \"method\": \"Deletion analysis, co-immunoprecipitation, cell fractionation\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal binding mapped by deletion analysis, phosphorylation-dependence demonstrated, replicated in multiple cell assays in the same study\",\n      \"pmids\": [\"8650580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"ZPR1 binds to eukaryotic translation elongation factor-1alpha (eEF-1alpha); EGF treatment induces this interaction and the co-redistribution of both proteins to the nucleus. In yeast, disruption of the ZPR1-eEF-1alpha interaction by mutation causes G2/M accumulation and defective growth, which is rescued by reconstituting the interaction.\",\n      \"method\": \"Co-immunoprecipitation, mutational analysis, genetic complementation, cell fractionation, yeast growth assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — genetic epistasis via reconstitution rescue, mutational disruption, and orthogonal biochemical co-IP across two organisms\",\n      \"pmids\": [\"9852145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"ZPR1 accumulates in the nucleolus of proliferating cells; ZPR1 gene disruption causes loss of nucleolar function including disruption of pre-ribosomal RNA expression, and cells lacking ZPR1 are not viable.\",\n      \"method\": \"Gene disruption (knockout), subcellular fractionation, fluorescence microscopy, pre-rRNA expression analysis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization with functional consequence (nucleolar disruption, pre-rRNA defect) established by gene disruption with specific molecular readout\",\n      \"pmids\": [\"9763455\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"ZPR1 interacts with the SMN protein and both proteins co-localize in subnuclear structures including gems and Cajal bodies; serum stimulation causes redistribution of SMN and ZPR1 from cytoplasm to nucleus, a process disrupted in SMA type I patient cells with SMN1 mutations. Decreased ZPR1 expression prevents SMN localization to nuclear bodies.\",\n      \"method\": \"Co-immunoprecipitation, fluorescence microscopy, siRNA/antisense knockdown, patient cell analysis\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, direct localization experiment with functional consequence, validated in patient cells and knockdown models\",\n      \"pmids\": [\"11283611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Cyclophilin A (Cpr1p) PPIase activity is required for nuclear export of Zpr1p in yeast; in cpr1Δ cells or with CPR1-dependent ZPR1 mutant alleles, Zpr1p accumulates in the nucleus due to defective export. PPIase activity of cyclophilins and structurally unrelated PPIase Fpr1p can suppress this defect, and overexpression of EF1alpha (a Zpr1p binding partner) also suppresses it.\",\n      \"method\": \"Yeast genetics (suppressor screen), nuclear export kinetic studies, fluorescence microscopy, mutant cyclophilin complementation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with transport kinetics, multiple orthogonal suppressors tested, PPIase activity correlation established\",\n      \"pmids\": [\"12242280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Targeted ablation of Zpr1 in mice disrupts subcellular localization of SMN to Cajal bodies and gems, and reduces cytoplasmic snRNP levels. Zpr1-/- mice die during early embryonic development with reduced proliferation and increased apoptosis. In motor neuron-like cells, siRNA-mediated ZPR1 depletion causes growth cone retraction, axonal defects, and apoptosis.\",\n      \"method\": \"Conditional gene knockout (mouse), siRNA knockdown, immunofluorescence microscopy, snRNP immunoprecipitation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knockout with specific molecular (snRNP, SMN localization) and cellular phenotypes, confirmed by siRNA in a second system\",\n      \"pmids\": [\"15767679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ZPR1 redistributes to the nucleus during S phase and co-localizes with SMN and the histone transcription factor NPAT at Cajal bodies associated with histone gene clusters. ZPR1 deficiency disrupts SMN and NPAT nuclear localization, blocks S-phase progression, arrests cells in G1 and G2 phases, and decreases histone gene expression.\",\n      \"method\": \"Cell cycle synchronization, fluorescence microscopy, siRNA knockdown, flow cytometry, RT-PCR for histone gene expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization tied to functional consequence (histone gene expression, cell cycle arrest) with multiple orthogonal readouts\",\n      \"pmids\": [\"17068332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ZPR1-deficient mice (heterozygous Zpr1 reduction) exhibit axonal pathology and neurodegeneration, identifying ZPR1 deficiency as a contributing factor in neurodegenerative disorders.\",\n      \"method\": \"Mouse model with targeted Zpr1 gene ablation, histopathological analysis of spinal cord\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single study, in vivo knockout with neurodegeneration phenotype but limited molecular mechanism detail in abstract\",\n      \"pmids\": [\"16648254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Crystal structure of the ZPR1 domain tandem revealed that each ZPR1 domain consists of an EIF2-like zinc finger and a double-stranded beta helix with a helical hairpin insertion. ZPR1 binds preferentially to GDP-bound eEF1A, does not directly influence nucleotide exchange kinetics or GTP hydrolysis, but efficiently displaces the exchange factor eEF1Bα from preformed nucleotide-free complexes, suggesting a role as a negative regulator of eEF1A activation. Structure-based mutagenesis identified a conserved eEF1A binding epitope required for normal cell growth, proliferation, and cell cycle progression.\",\n      \"method\": \"X-ray crystallography, biochemical binding assays, structure-based mutagenesis, complementation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure combined with mutagenesis, in vitro biochemical assays, and functional complementation in a single rigorous study\",\n      \"pmids\": [\"17704259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A ZPR1 deletion mutant (ΔA, Δ193-246) binds eEF1alpha constitutively and independently of Zn2+ in vivo, defining a region that normally controls the Zn2+-dependence of the ZPR1-eEF1alpha interaction.\",\n      \"method\": \"Mutational analysis, co-immunoprecipitation in vivo\",\n      \"journal\": \"Bioscience, biotechnology, and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single co-IP/pulldown approach, single lab, limited mechanistic follow-up\",\n      \"pmids\": [\"19966453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In Drosophila, Zpr1 is required downstream of both EGFR and FGFR signaling for tracheal subcellular lumen formation; Zpr1 mutations block lumen maturation, EGFR down-regulation phenocopies Zpr1 mutation, and Zpr1 is epistatic to EGFR overexpression-driven lumen formation. Reduction of Smn (a ZPR1-interacting protein) produces similar defects.\",\n      \"method\": \"Forward genetic mosaic screen, genetic epistasis analysis, RNAi knockdown in Drosophila\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with multiple pathways, confirmed by orthogonal RNAi and morphological readouts in single study\",\n      \"pmids\": [\"23029159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ZPR1 functions downstream of SMN to regulate HoxA5 levels in phrenic motor neurons; spatiotemporal inactivation of Zpr1 in motor neurons down-regulates HoxA5 and causes defects in phrenic motor neuron function resulting in respiratory failure and perinatal lethality in mice. Modulation of ZPR1 levels directly correlates with HoxA5 transcription levels in SMA mice.\",\n      \"method\": \"Conditional motor neuron-specific Zpr1 knockout (mouse), quantitative gene expression analysis, respiratory function assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional in vivo knockout with specific molecular target (HoxA5) and functional respiratory phenotype, direct correlation between ZPR1 and HoxA5 levels\",\n      \"pmids\": [\"28811488\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ZNF259/ZPR1 promotes breast cancer cell invasion and migration by activating the ERK/GSK3β/Snail signaling pathway; ZNF259 knockdown reduces p-ERK, p-GSK3β, and Snail and upregulates E-cadherin/ZO-1, while ZNF259 overexpression has the opposite effects. ERK inhibitor U0126 reverses effects of ZNF259 overexpression.\",\n      \"method\": \"siRNA knockdown, plasmid overexpression, Western blotting, Matrigel invasion assay, wound healing assay, pharmacological inhibition\",\n      \"journal\": \"Cancer management and research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — loss-of-function and gain-of-function with pathway inhibitor rescue, multiple cellular readouts, single lab\",\n      \"pmids\": [\"30214308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A homozygous missense mutation in ZPR1 (p.Ile196Thr) causes complete loss of ZPR1 protein in patient fibroblasts and a cell cycle defect with a significant number of cells arrested in G1 phase; structural modeling indicates this mutation disrupts the hydrophobic core of ZPR1.\",\n      \"method\": \"Exome sequencing, Western blot (no detectable ZPR1 protein), flow cytometry cell cycle analysis, structural modeling\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — human mutation with molecular (protein loss) and cellular (G1 arrest) phenotype, structural model supporting mechanism, single study\",\n      \"pmids\": [\"29851065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ZPR1-dependent neurodegeneration is mediated by the JNK signaling pathway, specifically through CNS-specific JNK3; ZPR1 deficiency activates the MLK3→MKK7→JNK3 cascade, phosphorylates c-Jun, and activates caspase-mediated neuron degeneration. Neurons from Jnk3-null mice are resistant to ZPR1-dependent neurodegeneration, and pharmacologic JNK inhibition reduces degeneration.\",\n      \"method\": \"Mouse genetic models (Jnk3 knockout, Zpr1-deficient), pharmacological JNK inhibition, Western blotting for signaling intermediates, apoptosis assays\",\n      \"journal\": \"Journal of experimental neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis (Jnk3 null rescue) plus pharmacological inhibition plus molecular pathway validation in multiple orthogonal approaches\",\n      \"pmids\": [\"31488953\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ZNF259/ZPR1 depletion in lung cancer cells leads to enhanced p-FAK and p-AKT, CyclinD1, and MMP2 levels, increasing proliferation and invasion; effects are reversed by specific FAK or AKT inhibitors, placing ZNF259 upstream of the FAK-AKT pathway as an inhibitor.\",\n      \"method\": \"siRNA knockdown, Western blotting, invasion and proliferation assays, pharmacological inhibition\",\n      \"journal\": \"Cancer management and research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — loss-of-function with pathway inhibitor rescue and multiple readouts, single lab\",\n      \"pmids\": [\"29276408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ZPR1 binds to RNA polymerase II and interacts in vivo with the SMN locus to upregulate SMN2 expression; ZPR1 overexpression in vivo increases SMN levels systemically and rescues severe SMA in mice. Low ZPR1 levels cause accumulation of co-transcriptional R-loops and DNA damage; ZPR1 complementation elevates senataxin levels, reduces R-loop accumulation and rescues DNA damage in SMA mice, motor neurons, and patient cells.\",\n      \"method\": \"Co-immunoprecipitation with RNA Pol II, chromatin immunoprecipitation (ChIP) at SMN locus, in vivo transgenic overexpression, R-loop detection assays (S9.6 antibody), DNA damage assays, senataxin protein quantification\",\n      \"journal\": \"Brain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches (ChIP, Co-IP, in vivo rescue, R-loop quantification, DNA damage) across patient cells and mouse models in a single comprehensive study\",\n      \"pmids\": [\"31828288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Zpr1 is a bespoke chaperone dedicated to eEF1A biogenesis; Zpr1 depletion causes acute proteotoxicity from misfolded eEF1A biosynthesis, and prolonged depletion causes eEF1A insufficiency inducing the integrated stress response and inhibiting protein synthesis. Biochemical reconstitution demonstrated that Zpr1 enables eEF1A to achieve a protease-resistant conformational state. ColabFold structural modeling revealed that Zpr1's zinc-finger and alpha-helical hairpin structures mediate the folding mechanism.\",\n      \"method\": \"Biochemical reconstitution (two approaches), protease protection assay, structural modeling (ColabFold), yeast genetic depletion, polysome profiling\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — two independent biochemical reconstitutions, structural modeling with functional validation, multiple genetic and cell biological readouts in a single rigorous study\",\n      \"pmids\": [\"36630955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Folding of eEF1A by Zpr1 requires GTP hydrolysis by eEF1A. The conserved protein Aim29 acts as a Zpr1 co-chaperone that recognizes eEF1A in the GTP-bound pre-hydrolysis conformation, dampens Zpr1·eEF1A GTPase activity, and facilitates client exit from the folding cycle.\",\n      \"method\": \"Biochemical reconstitution, GTPase activity assays, yeast genetics, fluorescence microscopy, structural modeling\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biochemical reconstitution with GTPase assays and genetic validation, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"37597513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ZPR1 assembles via liquid-liquid phase separation (LLPS) in vitro and regulates CHOP-mediated UPRER at the transcriptional level. ZPR1 binding to K63-ubiquitin chains promotes its LLPS. The bacterial effector NleE (from EPEC) disrupts ZPR1 binding to K63-ubiquitin chains, thereby inhibiting ZPR1 LLPS and suppressing host UPRER.\",\n      \"method\": \"Proximity-enabled protein crosslinking (to identify interaction), in vitro LLPS assay, ubiquitin chain binding assay, CHOP transcription reporter assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — novel interaction identified by crosslinking, LLPS and ubiquitin binding validated in vitro, transcriptional function shown, single lab\",\n      \"pmids\": [\"37379216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ZPR1 depletion decreased viral (HPV) R-loops while enhancing cellular R-loops, and increased SETX binding to the viral promoter. E2-ZPR1-SETX complex was detected. ZPR1 is thus not required for HPV R-loop resolution but regulates host R-loop dynamics, in contrast to its previously described role in resolving R-loops in mammalian cells.\",\n      \"method\": \"Co-immunoprecipitation (E2-SETX-ZPR1 complex), siRNA depletion, R-loop detection (S9.6), ChIP for SETX at viral promoter\",\n      \"journal\": \"Viruses\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Weak — single study, siRNA depletion with R-loop and ChIP readouts; the negative finding (ZPR1 not required for HPV R-loop resolution) is mechanistically informative\",\n      \"pmids\": [\"41305523\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ZPR1 (ZNF259) is an essential, highly conserved zinc-finger protein that acts as a bespoke chaperone for eEF1A biogenesis (enabling its proper folding through a GTPase-regulated cycle assisted by the co-chaperone Aim29), translocates from cytoplasm to nucleus in response to mitogenic signals (including EGF via EGFR tyrosine kinase interaction), accumulates in the nucleolus and Cajal bodies where it is required for pre-rRNA expression and histone gene transcription, regulates SMN complex localization to nuclear bodies (with deficiency causing SMA-like neurodegeneration via JNK3-mediated apoptosis), upregulates SMN2 expression through RNA Pol II interaction and prevents genomic instability by maintaining senataxin levels to resolve co-transcriptional R-loops, and undergoes liquid-liquid phase separation regulated by K63-ubiquitin binding to modulate the UPRER.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ZPR1 (ZNF259) is an essential, zinc-finger protein that couples eEF1A biogenesis to mitogenic signaling and nuclear organization [#1, #2, #17]. Its core biochemical activity is to act as a dedicated chaperone for the translation elongation factor eEF1A: ZPR1 binds preferentially the GDP-bound form of eEF1A through a conserved binding epitope, displaces the exchange factor eEF1Bα, and drives eEF1A into a protease-resistant folded state via a GTP-hydrolysis-dependent cycle assisted by the co-chaperone Aim29 [#8, #17, #18]. Loss of ZPR1 causes proteotoxic accumulation of misfolded eEF1A, eEF1A insufficiency, induction of the integrated stress response, and inhibition of protein synthesis [#17]. In quiescent cells ZPR1 is held at the cytoplasmic tyrosine kinase domain of EGFR; EGF-induced receptor tyrosine phosphorylation releases ZPR1, which redistributes with eEF1A to the nucleus, accumulates in the nucleolus, and is required for pre-rRNA expression and cell viability [#0, #1, #2]. During S phase ZPR1 co-localizes with SMN and the histone transcription factor NPAT in Cajal bodies, where it is required for SMN and NPAT nuclear localization, histone gene expression, and cell-cycle progression [#3, #6]. ZPR1 regulates SMN biology directly: it binds RNA polymerase II at the SMN locus to upregulate SMN2, and maintains senataxin levels to resolve co-transcriptional R-loops and prevent DNA damage, so that ZPR1 deficiency drives SMA-like motor neuron degeneration through an MLK3→MKK7→JNK3 apoptotic cascade [#14, #16]. A homozygous p.Ile196Thr missense mutation that abolishes ZPR1 protein causes a G1 cell-cycle defect in patient fibroblasts, establishing ZPR1 loss as a human disease determinant [#13]. ZPR1 additionally assembles by K63-ubiquitin-promoted liquid-liquid phase separation to regulate CHOP-mediated UPRER transcription [#19].\"\n  ,\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established the first molecular handle on ZPR1 by showing it is a signaling-responsive partner of a receptor tyrosine kinase, linking growth-factor input to ZPR1 relocalization.\",\n      \"evidence\": \"Deletion mapping and co-IP showing zinc-finger binding to EGFR subdomains X/XI with phosphorylation-dependent release and nuclear accumulation\",\n      \"pmids\": [\"8650580\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify downstream nuclear targets of released ZPR1\", \"Functional consequence of EGFR binding for translation or proliferation untested\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identified eEF1A as a core ZPR1 partner and demonstrated the interaction is functionally essential, tying ZPR1 to translation machinery and cell-cycle progression.\",\n      \"evidence\": \"Co-IP, mutational disruption with reconstitution rescue, and cell fractionation in mammalian cells and yeast\",\n      \"pmids\": [\"9852145\", \"9763455\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of how ZPR1 acts on eEF1A undefined\", \"Whether the eEF1A interaction explains nucleolar/pre-rRNA requirement unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Connected ZPR1 to the SMN pathway, showing ZPR1 is required for SMN delivery to nuclear bodies, providing a mechanistic basis for ZPR1 involvement in spinal muscular atrophy.\",\n      \"evidence\": \"Reciprocal co-IP, immunofluorescence in gems/Cajal bodies, knockdown, and SMA type I patient cell analysis\",\n      \"pmids\": [\"11283611\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish whether ZPR1 acts on SMN transcription or trafficking\", \"Mechanism of serum-stimulated co-redistribution not defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined how ZPR1 nuclear export is controlled, showing PPIase (cyclophilin) activity and eEF1A availability govern its shuttling.\",\n      \"evidence\": \"Yeast suppressor genetics, nuclear export kinetics, and cyclophilin complementation\",\n      \"pmids\": [\"12242280\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct prolyl isomerization of ZPR1 not demonstrated\", \"Mammalian relevance of cyclophilin-dependent export untested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated ZPR1 is essential in vivo and required for SMN/snRNP nuclear body assembly and motor neuron integrity.\",\n      \"evidence\": \"Mouse Zpr1 knockout (embryonic lethal), siRNA in motor neuron-like cells, snRNP IP, and immunofluorescence\",\n      \"pmids\": [\"15767679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular cause of apoptosis not yet defined\", \"Tissue-specific requirements not dissected\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Linked ZPR1 to S-phase histone gene transcription and confirmed its in vivo role in neurodegeneration.\",\n      \"evidence\": \"Cell-cycle synchronization with NPAT/Cajal body colocalization, histone RT-PCR, and Zpr1-reduced mouse spinal cord histopathology\",\n      \"pmids\": [\"17068332\", \"16648254\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ZPR1 occupancy at histone loci not shown\", \"Connection between histone transcription role and neurodegeneration unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Provided structural and biochemical mechanism for the ZPR1–eEF1A interaction, defining ZPR1 as a regulator of eEF1A nucleotide state.\",\n      \"evidence\": \"Crystal structure of ZPR1 domain tandem, binding assays showing GDP-eEF1A preference and eEF1Bα displacement, and structure-guided mutagenesis with complementation\",\n      \"pmids\": [\"17704259\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular consequence of eEF1Bα displacement not directly measured\", \"Did not yet identify the chaperone activity later described\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Mapped a regulatory region (residues 193–246) that confers Zn2+-dependence on the ZPR1–eEF1A interaction.\",\n      \"evidence\": \"Deletion mutant (ΔA) co-IP showing constitutive, Zn2+-independent eEF1A binding\",\n      \"pmids\": [\"19966453\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single co-IP approach without orthogonal validation\", \"Structural basis of Zn2+ regulation not resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Placed ZPR1 within receptor tyrosine kinase developmental signaling in an organismal context, downstream of EGFR/FGFR.\",\n      \"evidence\": \"Drosophila genetic mosaic screen and epistasis for tracheal lumen formation, with Smn phenocopy\",\n      \"pmids\": [\"23029159\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular target of ZPR1 in lumen formation unknown\", \"Relationship to translation/eEF1A role not addressed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified HoxA5 as a ZPR1-dependent transcriptional output critical for motor neuron function, linking ZPR1/SMN to respiratory phenotypes.\",\n      \"evidence\": \"Motor neuron-specific conditional Zpr1 knockout in mice with HoxA5 expression analysis and respiratory assays\",\n      \"pmids\": [\"28811488\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ZPR1 regulates HoxA5 directly or via SMN unclear\", \"Mechanism connecting HoxA5 to phrenic neuron survival not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Revealed ZPR1 loss causes a human cell-cycle disease phenotype and that ZPR1 modulates oncogenic signaling, broadening its physiological scope.\",\n      \"evidence\": \"Patient exome (p.Ile196Thr, protein loss, G1 arrest) and ERK/GSK3β/Snail pathway manipulation in breast cancer cells with inhibitor rescue\",\n      \"pmids\": [\"29851065\", \"30214308\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Disease entity caused by the mutation not fully characterized\", \"Direct vs indirect effect on ERK/Snail signaling not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined the apoptotic effector pathway of ZPR1 deficiency (JNK3) and an additional tumor-suppressive signaling context (FAK-AKT).\",\n      \"evidence\": \"Jnk3-null genetic rescue plus pharmacological JNK inhibition for neurodegeneration; siRNA with FAK/AKT inhibitor rescue in lung cancer cells\",\n      \"pmids\": [\"31488953\", \"29276408\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream trigger linking ZPR1 loss to MLK3 activation unknown\", \"Whether translation defects drive JNK3 activation untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established a direct gene-regulatory mechanism by which ZPR1 upregulates SMN2 and protects the genome from R-loop-driven damage via senataxin.\",\n      \"evidence\": \"RNA Pol II co-IP, ChIP at the SMN locus, in vivo transgenic overexpression rescue of SMA, S9.6 R-loop and DNA damage assays, and senataxin quantification\",\n      \"pmids\": [\"31828288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which ZPR1 maintains senataxin levels unresolved\", \"Whether transcriptional and chaperone functions are mechanistically linked unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Resolved the molecular function of ZPR1 as a bespoke eEF1A folding chaperone operating through a GTP-hydrolysis cycle with co-chaperone Aim29.\",\n      \"evidence\": \"Two independent biochemical reconstitutions, protease-protection assays, GTPase assays, ColabFold modeling, and yeast genetics\",\n      \"pmids\": [\"36630955\", \"37597513\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution structure of the ZPR1·eEF1A·Aim29 folding intermediate lacking\", \"Human Aim29 ortholog and in-cell coupling to disease phenotypes not established\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Added a phase-separation-based regulatory mode, linking ZPR1 ubiquitin recognition to ER stress transcription and host-pathogen control.\",\n      \"evidence\": \"Proximity crosslinking, in vitro LLPS and K63-ubiquitin binding assays, CHOP reporter, and bacterial NleE effector disruption\",\n      \"pmids\": [\"37379216\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological trigger of ZPR1 LLPS in cells unconfirmed\", \"Relationship between LLPS and the eEF1A chaperone function unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Refined the R-loop role, showing ZPR1 regulates host versus viral R-loop dynamics differentially via a SETX-containing complex.\",\n      \"evidence\": \"E2-ZPR1-SETX co-IP, siRNA depletion, S9.6 R-loop detection, and SETX ChIP at the HPV promoter\",\n      \"pmids\": [\"41305523\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study with siRNA depletion\", \"Mechanism distinguishing host vs viral R-loop regulation unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ZPR1's distinct activities — cytoplasmic eEF1A chaperoning, nuclear SMN/SMN2 regulation, R-loop resolution, and phase separation — are coordinated within a single protein remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model integrating chaperone and transcriptional/genome-protective roles\", \"Mechanism of signal-dependent partitioning between functions unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [17, 18]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [16, 6]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [1, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1, 3]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [3, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [17, 18]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [16, 6]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 12, 15]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [6, 13]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [17, 19]}\n    ],\n    \"complexes\": [\"Cajal body\", \"ZPR1·eEF1A·Aim29 folding complex\"],\n    \"partners\": [\"EEF1A1\", \"SMN1\", \"EGFR\", \"NPAT\", \"SETX\", \"AIM29\", \"EEF1B\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}